Free Trial
ASX:ACR

Acrux (ACR) Stock Price, News & Analysis

Acrux logo

About Acrux Stock (ASX:ACR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
4,000 shs
Average Volume
N/A
Market Capitalization
A$12.47 million
P/E Ratio
N/A
Dividend Yield
11.66%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acrux and its competitors with MarketBeat's FREE daily newsletter.

ACR Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
South African group buys Cononish gold mine
See More Headlines

ACR Stock Analysis - Frequently Asked Questions

Acrux Limited (ASX:ACR) posted its earnings results on Thursday, February, 21st. The company reported ($0.02) earnings per share (EPS) for the quarter. Acrux had a negative net margin of 113.93% and a negative trailing twelve-month return on equity of 130.13%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acrux investors own include Altimmune (ALT), ANZ Group (ANZ), Lynas Rare Earths (LYC), MV Oil Trust (MVO), Organigram (OGI), BHP Group (BHP) and Beacon Roofing Supply (BECN).

Company Calendar

Last Earnings
2/21/2019
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Trading
Current Symbol
ASX:ACR
CIK
N/A
Fax
N/A
Employees
2,018
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$5.80 million
Net Margins
-113.93%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$5.09 million
Price / Cash Flow
1.57
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$12.47 million
Optionable
Not Optionable
Beta
1.21
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (ASX:ACR) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners